Section Arrow
SRZN.NASDAQ
- Surrozen
Quotes are at least 15-min delayed:2025/07/21 06:41 EDT
Pre Market
Last
 --
-- (--)
Bid
7.26
Ask
13.48
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 8.48
-0.02 (-0.24%)
Day High 
8.55 
Prev. Close
8.5 
1-M High
10.1 
Volume 
3.35K 
Bid
7.26
Ask
13.48
Day Low
8.2001 
Open
8.55 
1-M Low
Market Cap 
72.78M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.45 
20-SMA 8.74 
50-SMA 8.51 
52-W High 18.17 
52-W Low 5.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-24.86/-6.14
Enterprise Value
79.42M
Balance Sheet
Book Value Per Share
0.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.66M
Operating Revenue Per Share
1.46
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TELOTelomir Pharmaceuticals2.28+1.07+88.43%-- 
Pre Market 2.01 -0.27 -11.84%
SRPTSarepta Therapeutics14.075-7.895-35.94%15.76PE
Pre Market 13.1 -0.975 -6.93%
NCNANuCana plc0.0477+0.0009+1.92%-- 
Pre Market 0.0474 -0.0003 -0.63%
RXRXRecursion Pharmaceuticals5.84+0.32+5.80%-- 
Pre Market 6.22 +0.38 +6.51%
MEIPMEI Pharma5.92+1.42+31.56%1.09PE
Pre Market 6.06 +0.14 +2.36%
Quotes are at least 15-min delayed:2025/07/21 06:41 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.